A Lithuania court upheld on Monday a 35.7 million euro antitrust fine on Russian gas giant Gazprom for restricting competition in the Baltic state.
In June last year Lithuania’s Competition Council fined Gazprom, the sole gas supplier in the country at that time, for refusing to negotiate a virtual gas swap with state-owned energy group Lietuvos Energija.
By refusing to negotiate the swap deal, Gazprom had sought to retain its monopoly, and therefore the Competition Council had a right to impose the fine, the Vilnius Regional Administrative Court said in its verdict on Monday, dismissing Gazprom’s appeal.
Lietuvos Energija had wanted to buy cheaper gas in Germany and swap it for more expensive gas delivered by Gazprom to Lithuania.
Gazprom sold its stakes in Lithuanian gas utility Lietuvos Dujos and a grid company Amber Grid soon after the Competition Council’s decision to impose the fine.
Lithuania opened a floating liquefied natural gas (LNG) terminal at the end of 2014, to reduce its dependence on Russia, and started to import super-cooled gas by tankers from Norway, ending Gazprom’s supply monopoly.
In September this year, the Russian supplier rejected EU antitrust charges that it had abused its dominant position by levying excessive prices on customers in eastern Europe. Gazprom said the charges had no economic or legal basis.
Full content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas